Globe Life Inc. (NYSE:GL) Shares Acquired by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC increased its position in shares of Globe Life Inc. (NYSE:GL - Free Report) by 61.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 24,665 shares of the company's stock after buying an additional 9,395 shares during the period. Steward Partners Investment Advisory LLC's holdings in Globe Life were worth $2,751,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in GL. Nuance Investments LLC boosted its position in shares of Globe Life by 155.6% during the 3rd quarter. Nuance Investments LLC now owns 1,138,978 shares of the company's stock worth $120,629,000 after acquiring an additional 693,346 shares in the last quarter. Swedbank AB acquired a new position in Globe Life in the fourth quarter valued at approximately $52,414,000. Proficio Capital Partners LLC increased its stake in Globe Life by 11,153.5% in the fourth quarter. Proficio Capital Partners LLC now owns 445,076 shares of the company's stock valued at $49,635,000 after purchasing an additional 441,121 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Globe Life by 22.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company's stock worth $160,949,000 after purchasing an additional 277,108 shares in the last quarter. Finally, Segall Bryant & Hamill LLC lifted its position in shares of Globe Life by 78.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 290,515 shares of the company's stock worth $30,768,000 after buying an additional 127,764 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several equities research analysts recently commented on GL shares. BMO Capital Markets started coverage on shares of Globe Life in a research note on Thursday, January 23rd. They set a "market perform" rating and a $114.00 price target on the stock. Evercore ISI raised Globe Life from an "in-line" rating to an "outperform" rating and boosted their target price for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Keefe, Bruyette & Woods raised their price target on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 12th. Wells Fargo & Company boosted their price objective on Globe Life from $126.00 to $141.00 and gave the company an "overweight" rating in a research note on Wednesday, February 19th. Finally, Jefferies Financial Group raised their target price on shares of Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a research report on Tuesday, December 10th. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Globe Life presently has a consensus rating of "Moderate Buy" and a consensus price target of $135.60.

Insiders Place Their Bets

In related news, CEO James Matthew Darden sold 24,890 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total value of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. This represents a 38.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 11,000 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $122.31, for a total value of $1,345,410.00. Following the transaction, the chief executive officer now directly owns 18,948 shares of the company's stock, valued at $2,317,529.88. The trade was a 36.73 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 61,338 shares of company stock worth $7,239,630. 1.51% of the stock is owned by corporate insiders.

Globe Life Stock Performance

GL traded up $2.21 during trading on Tuesday, reaching $124.79. The company's stock had a trading volume of 902,865 shares, compared to its average volume of 618,679. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. Globe Life Inc. has a 52-week low of $38.95 and a 52-week high of $131.39. The company has a market capitalization of $10.46 billion, a price-to-earnings ratio of 10.44 and a beta of 0.77. The company's fifty day moving average price is $120.09 and its 200-day moving average price is $111.64.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, equities analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be issued a dividend of $0.27 per share. The ex-dividend date is Thursday, April 3rd. This is a boost from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a yield of 0.87%. Globe Life's payout ratio is currently 9.04%.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.